CME Group (NASDAQ: CME) has had a rough month — down 17% in 30 days — and Wall Street analysts now think the selloff has gone too far. Keefe, Bruyette & Woods upgraded the exchange operator to Outperform from Market Perform on Thursday, maintaining its $305 price target. At Wednesday’s close, that target implies 21% upside. The call is a direct counter to the bearish narrative that has hammered CME shares: concern about the company’s push into perpetual futures contracts and its escalating regulatory battle with the Commodity Futures Trading Commission.
KBW analyst Chris Allen argued in a Thursday note that the perpetual futures risk is “overblown in general for exchanges and CME specifically.” The key reasons: CME has relatively low retail exposure compared to crypto-focused platforms where perpetual futures are most controversial, and the company’s equity index products are protected by long-term license agreements that are difficult to displace. Allen wrote that the “downward acceleration in recent weeks” has created an “attractive risk/reward” at current prices. CME CEO Terry Duffy escalated the legal standoff by announcing the company would sue the CFTC over its perpetual futures approvals — a bold move that signals management’s confidence in their legal position. CME is down nearly 8% year to date, making it one of the worst-performing large-cap financial stocks despite underlying business fundamentals that remain solid.
For investors, CME Group is one of the most defensible businesses in financial infrastructure — it operates exchanges with deep moats, strong recurring fee revenue, and meaningful exposure to volatility-driven trading volumes. The regulatory headline risk has created a discounted entry point that KBW believes is a buying opportunity. Of 17 Wall Street analysts covering CME, 8 now carry a Buy or Strong Buy rating. With interest rates elevated and macro uncertainty sustaining high trading volumes across futures markets, CME’s core business continues to generate strong cash flows. Investors willing to look past the CFTC noise could be picking up a blue-chip financial infrastructure stock at a meaningful discount to its longer-term value.
